News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Romano Kathryn
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/23/2023 |
4
| Romano Kathryn (Chief Accounting Officer) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 12,500 shares
@ $95.05, valued at
$1.2M
Sold 12,500 shares
@ $95.0449, valued at
$1.2M
Sold 3,428 shares
@ $95.0808, valued at
$325.9k
Sold 2,521 shares
@ $105.8036, valued at
$266.7k
Sold 2,570 shares
@ $106.8087, valued at
$274.5k
Sold 1,300 shares
@ $107.8777, valued at
$140.2k
Sold 2,955 shares
@ $109.1719, valued at
$322.6k
Sold 3,154 shares
@ $109.9933, valued at
$346.9k
Sold 12,500 shares
@ $110, valued at
$1.4M
Exercised 12,500 options to buy
@ $52.26, valued at
$653.3k
Exercised 12,500 options to buy
@ $52.26, valued at
$653.3k
|
|
| 05/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/28/2023 |
4
| Romano Kathryn (Chief Accounting Officer) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Paid exercise price by delivering 2,144 shares
@ $78.46, valued at
$168.2k
Granted 20,000 options to buy
@ $81.91, valued at
$1.6M
Granted 10,000 rights
@ $0 |
|
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|